PD-1HighCD8+ T cells activated through 4-1BB triggering eventually egressed from TDLNs, infiltrated into tumor tissues, and suppressed tumor growth during the early phase of anti-4-1BB therapy. The gene discussed is TNFRSF9; the disease is neoplasm.